Company performance
Add to research
Current Price
as of Mar 12, 2025$2.37
P/E Ratio
N/A
Market Cap
$15.79M
- KRMD
Description
Add to research
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerMEIP
- Price$2.37-1.66%
Trading Information
- Market cap$15.79M
- Float98.69%
- Average Daily Volume (1m)8,376
- Average Daily Volume (3m)19,310
- EPS-$5.74
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$2.68M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$3.45M
- EVN/A
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.71
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account